Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Photocure ASA Director's Dealing 2017

Apr 10, 2017

3714_dirs_2017-04-10_d5cf6e85-cb2f-4708-8076-d48edf42fbcd.html

Director's Dealing

Open in viewer

Opens in your device viewer

Photocure ASA (OSE: PHO): Mandatory notification of trade, primary insider

Photocure ASA (OSE: PHO): Mandatory notification of trade, primary insider

On 7 April 2017 Ambaw Bellete - Head, US Cancer Commercial

Operations - purchased 2,000 Photocure shares at a price of

NOK 30.13 each.

Ambaw Bellete now holds 2,000 shares and 76,600 options in

Photocure.

This notification is made pursuant to the Norwegian

Securities Trading Act sections 4-2.